N.E. Gilhus, S. Tzartos, A. Evoli, J. Palace, T.M. Burns, J. Verschuuren, Myasthenia gravis. Nat. Rev. Dis. Prim. 5(1), 30 (2019)

Article  PubMed  Google Scholar 

N.E. Gilhus, Myasthenia gravis. N. Engl. J. Med. 375(26), 2570–2581 (2016)

Article  CAS  PubMed  Google Scholar 

R. Marcus, What is myasthenia gravis? JAMA 331(5), 452 (2024)

Article  PubMed  Google Scholar 

A.S. Carr, C.R. Cardwell, P.O. McCarron, J. McConville, A systematic review of population based epidemiological studies in myasthenia gravis. BMC Neurol. 10, 46 (2010)

Article  PubMed  PubMed Central  Google Scholar 

D. Menon, V. Bril, Pharmacotherapy of generalized myasthenia gravis with special emphasis on newer biologicals. Drugs 82(8), 865–887 (2022)

Article  CAS  PubMed  PubMed Central  Google Scholar 

N.E. Gilhus, J.J. Verschuuren, Myasthenia gravis: subgroup classification and therapeutic strategies. Lancet Neurol. 14(10), 1023–1036 (2015)

Article  CAS  PubMed  Google Scholar 

T. Katsuyama, K.E. Sada, S. Namba, H. Watanabe, E. Katsuyama, T. Yamanari et al. Risk factors for the development of glucocorticoid-induced diabetes mellitus. Diab. Res. Clin. Pr. 108(2), 273–279 (2015)

Article  CAS  Google Scholar 

J.L. Hwang, R.E. Weiss, Steroid-induced diabetes: a clinical and molecular approach to understanding and treatment. Diab. Metab. Res. Rev. 30(2), 96–102 (2014)

Article  CAS  Google Scholar 

E. de Sousa, J. Howard, More evidence for the association between statins and myasthenia gravis. Muscle Nerve 38(3), 1085–1086 (2008)

Article  PubMed  Google Scholar 

S. Sheikh, U. Alvi, B. Soliven, K. Rezania, Drugs that induce or cause deterioration of myasthenia gravis: an update. J. Clin. Med. 10(7), 1537 (2021)

Article  CAS  PubMed  PubMed Central  Google Scholar 

Y. Zhu, B. Wang, Y. Hao, R. Zhu, Clinical features of myasthenia gravis with neurological and systemic autoimmune diseases. Front. Immunol. 14, 1223322 (2023)

Article  CAS  PubMed  PubMed Central  Google Scholar 

A. Nacu, J.B. Andersen, V. Lisnic, J.F. Owe, N.E. Gilhus, Complicating autoimmune diseases in myasthenia gravis: a review. Autoimmunity 48(6), 362–368 (2015)

Article  CAS  PubMed  PubMed Central  Google Scholar 

U.K. Misra, J. Kalita, V.K. Singh, S. Kumar, A study of comorbidities in myasthenia gravis. Acta Neurol. Belg. 120(1), 59–64 (2020)

Article  PubMed  Google Scholar 

H.N. Ozdemir, H. Karasoy, A.N. Yuceyar, O. Ekmekci, Effects of comorbid diseases on clinical outcomes in patients with myasthenia gravis. Neurol. Sci. 44(8), 2923–2931 (2023)

Article  PubMed  Google Scholar 

H. Sun, P. Saeedi, S. Karuranga, M. Pinkepank, K. Ogurtsova, B.B. Duncan et al. IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diab. Res. Clin. Pr. 18, 3109119 (2022)

Google Scholar 

C.G. Croitoru, M. Pavel-Tanasa, D.I. Cuciureanu, D.N. Hodorog, P. Cianga, Autoimmune and non-autoimmune comorbidities in myasthenic patients of East-European Descent: a case-control study. J. Clin. Med. 13(8), 2273 (2024)

Article  PubMed  PubMed Central  Google Scholar 

M.J. Page, J.E. McKenzie, P.M. Bossuyt, I. Boutron, T.C. Hoffmann, C.D. Mulrow et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Bmj 372, n71 (2021)

Article  PubMed  PubMed Central  Google Scholar 

A. Stang, Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur. J. Epidemiol. 25(9), 603–605 (2010)

Article  PubMed  Google Scholar 

A D.C. Rostom, A. Cranney, et al. Celiac Disease. Rockville (MD): Agency for Healthcare Research and Quality (US); 2004 Sep. (Evidence Reports/Technology Assessments, No. 104.) Appendix D. Quality Assessment Forms. Available from: https://www.ncbi.nlm.nih.gov/books/NBK35156/.

K. Li, Y. Ouyang, H. Yang, Myasthenia gravis and five autoimmune diseases: a bidirectional Mendelian randomization study. Neurol. Sci. 45(4), 1699–1706 (2024)

Article  CAS  PubMed  Google Scholar 

R.H. Song, Q.M. Yao, B. Wang, Q. Li, X. Jia, J.A. Zhang, Thyroid disorders in patients with myasthenia gravis: a systematic review and meta-analysis. Autoimmun. Rev. 18(10), 102368 (2019)

Article  CAS  PubMed  Google Scholar 

X. Zhou, S. Cao, J. Hou, T. Gui, F. Zhu, Q. Xue, Association between myasthenia gravis and cognitive disorders: a PRISMA-compliant meta-analysis. Int. J. Neurosci. 133(9), 987–998 (2023)

Article  CAS  PubMed  Google Scholar 

C.J. Lin, Y.S. Lee, J.H. Yeh, S.J. Liu, K.Y. Lin, The association between myasthenia gravis and risk of fracture: a systematic review and meta-analysis. Osteoporos. Int. 35(10), 1709–1717 (2024)

Article  PubMed  Google Scholar 

P. Yingchoncharoen, N. Charoenngam, B. Ponvilawan, J. Thongpiya, T. Chaikijurajai, P. Ungprasert, The association between asthma and risk of myasthenia gravis: a systematic review and meta-analysis. Lung 199(3), 273–280 (2021)

Article  PubMed  Google Scholar 

J. Nadali, N. Ghavampour, F. Beiranvand, M. Maleki Takhtegahi, M.E. Heidari, S. Salarvand et al. Prevalence of depression and anxiety among myasthenia gravis (MG) patients: a systematic review and meta-analysis. Brain Behav. 13(1), e2840 (2023)

Article  CAS  PubMed  Google Scholar 

L. O’Connor, C. Malmeström, R. Da Silva Rodrigues, S. Brauner, A.K. Wikström, A.R. Punga, Pregnancy outcomes for women with myasthenia gravis and their newborns: a nationwide register-based cohort study. Eur. J. Neurol. 31(1), e16100 (2024)

Article  PubMed  Google Scholar 

S.P. Shen, K.J. Herr, Y. Liu, C.C. Yang, C.H. Tang, Healthcare resource utilization and costs associated with generalized myasthenia gravis: a retrospective matched cohort study using the National Health Insurance Research Database in Taiwan. Front. Neurol. 14, 1216595 (2023)

Article  PubMed  PubMed Central  Google Scholar 

K.J. Herr, S.P. Shen, Y. Liu, C.C. Yang, C.H. Tang, The growing burden of generalized myasthenia gravis: a population-based retrospective cohort study in Taiwan. Front. Neurol. 14, 1203679 (2023)

Article  PubMed  PubMed Central  Google Scholar 

L. Harris, S. Graham, S. MacLachlan, A. Exuzides, S. Jacob, A retrospective longitudinal cohort study of the clinical burden in myasthenia gravis. BMC Neurol. 22(1), 172 (2022)

Article  PubMed  PubMed Central  Google Scholar 

J.S. Park, K.Y. Eah, J.M. Park, Epidemiological profile of myasthenia gravis in South Korea using the national health insurance database. Acta Neurol. Scand. 145(5), 633–640 (2022)

Article  CAS  PubMed  Google Scholar 

L. Nicholls-Dempsey, N. Czuzoj-Shulman, H.A. Abenhaim, Maternal and neonatal outcomes among pregnant women with myasthenia gravis. J. Perinat. Med. 48(8), 793–798 (2020)

Article  PubMed  Google Scholar 

H.T. Chu, C.C. Tseng, C.S. Liang, T.C. Yeh, L.Y. Hu, A.C. Yang et al. Risk of depressive disorders following myasthenia gravis: a nationwide population-based retrospective cohort study. Front. Psychiatry 10, 481 (2019)

Article  PubMed  PubMed Central  Google Scholar 

J.H. Yeh, H.J. Chen, C.C. Lin, Y.K. Chen, H.C. Chiu, C.H. Kao, Risk of diabetes mellitus among patients with myasthenia gravis. Acta Neurol. Scand. 132(2), 132–138 (2015)

Article  CAS  PubMed  Google Scholar 

F. Fang, O. Sveinsson, G. Thormar, M. Granqvist, J. Askling, I.E. Lundberg et al. The autoimmune spectrum of myasthenia gravis: a Swedish p